Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Investigation of UDP-glucuronosyltransferases (UGTs) inhibitory properties of carvacrol.

Dong RH, Fang ZZ, Zhu LL, Liang SC, Ge GB, Yang L, Liu ZY.

Phytother Res. 2012 Jan;26(1):86-90. doi: 10.1002/ptr.3525. Epub 2011 May 5.

PMID:
21544887
2.
3.

Inhibition potential of glimepiride (gli) towards important UDP-glucuronosyltransferase (UGT) isoforms in human liver.

Fu JF, Ren QY, Zhang NY, Gao B, Tu YY, Fu GQ, Li DH, Zhang YS.

Pharmazie. 2012 Aug;67(8):715-7.

PMID:
22957438
4.

Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs).

Fang ZZ, Cao YF, Hu CM, Hong M, Sun XY, Ge GB, Liu Y, Zhang YY, Yang L, Sun HZ.

Toxicol Appl Pharmacol. 2013 Mar 1;267(2):149-54. doi: 10.1016/j.taap.2012.12.019. Epub 2013 Jan 7.

PMID:
23306165
5.

Tacrolimus strongly inhibits multiple human UDP-glucuronosyltransferase (UGT) isoforms.

Liu XY, Fang ZZ, Dong PP, Shi XH, Teng YJ, Sun XY.

Pharmazie. 2012 Sep;67(9):804-8.

PMID:
23016456
6.

Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation.

Lu H, Fang ZZ, Cao YF, Hu CM, Hong M, Sun XY, Li H, Liu Y, Fu X, Sun H.

Fitoterapia. 2013 Jan;84:208-12. doi: 10.1016/j.fitote.2012.12.002. Epub 2012 Dec 10.

PMID:
23237733
7.
8.

Strong inhibition of deoxyschizandrin and schisantherin A toward UDP-glucuronosyltransferase (UGT) 1A3 indicating UGT inhibition-based herb–drug interaction.

Liu C, Cao YF, Fang ZZ, Zhang YY, Hu CM, Sun XY, Huang T, Zeng J, Fan XR, Mo H.

Fitoterapia. 2012 Dec;83(8):1415-9.

PMID:
23339253
9.
10.

Demethylzeylasteral exhibits strong inhibition towards UDP-glucuronosyltransferase (UGT) 1A6 and 2B7.

Zhao JW, Wang GH, Chen M, Cheng LH, Ji XQ.

Molecules. 2012 Aug 8;17(8):9469-75. doi: 10.3390/molecules17089469.

11.

Glycyrrhetinic acid exhibits strong inhibitory effects towards UDP-glucuronosyltransferase (UGT) 1A3 and 2B7.

Huang YP, Cao YF, Fang ZZ, Zhang YY, Hu CM, Sun XY, Yu ZW, Zhu X, Hong M, Yang L, Sun HZ.

Phytother Res. 2013 Sep;27(9):1358-61. doi: 10.1002/ptr.4875. Epub 2012 Nov 12.

PMID:
23148031
12.

Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.

Uchaipichat V, Mackenzie PI, Guo XH, Gardner-Stephen D, Galetin A, Houston JB, Miners JO.

Drug Metab Dispos. 2004 Apr;32(4):413-23. Erratum in: Drug Metab Dispos. 2005 Dec;33(12):1925-6.

14.

Probe substrate and enzyme source-dependent inhibition of UDP-glucuronosyltransferase (UGT) 1A9 by wogonin.

Chengcheng G, Rui X, Tianheng M, Wei Y, Liqun P.

Afr Health Sci. 2013 Sep;13(3):551-5. doi: 10.4314/ahs.v13i3.3.

15.

Comparison of the drug-drug interactions potential of erlotinib and gefitinib via inhibition of UDP-glucuronosyltransferases.

Liu Y, Ramírez J, House L, Ratain MJ.

Drug Metab Dispos. 2010 Jan;38(1):32-9. doi: 10.1124/dmd.109.029660.

16.

Structure-inhibition relationship of podophyllotoxin (PT) analogues towards UDP-glucuronosyltransferase (UGT) isoforms.

Qi JQ, Cao YF, Sun XY, Hong M, Fang ZZ, Meng DL, Sun DX.

Pharmazie. 2015 Apr;70(4):239-43.

PMID:
26012253
17.

Arbidol exhibits strong inhibition towards UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.

Liu X, Huang T, Chen JX, Zeng J, Fan XR, Xu-Zhu, Yu ZW, Sun XY, Hong M, Sun HZ.

Pharmazie. 2013 Dec;68(12):945-50.

PMID:
24400440
19.

Development of an assay using 4-trifluoromethylumbelliferyl as a marker substrate for assessment of drug-drug interactions to multiple isoforms of UDP-glucuronosyltransferases.

Baranczewski P, Kallin A, Andersson A, Hagigi S, Aberg M, Postlind H, Mankowitz L.

Assay Drug Dev Technol. 2004 Aug;2(4):345-52.

PMID:
15357915
20.

Inhibitory potential of chlormadinone acetate (CMA) on five important UDP-glucuronosyltransferases in human liver.

Huang T, Fang ZZ, Zhang YY, Zhu LL, Feng LL, Zheng W, Cao YF, Sun DX, Yang L.

Pharmazie. 2011 Mar;66(3):212-5.

PMID:
21553653

Supplemental Content

Support Center